Mastering the Management of Aortic Valve Disease: A Case Based Approach

presented by Cleveland Clinic

5 others would like to attend.

I need an invite

Notification icon Friday, December 13, 2019 7 AM - Saturday, December 14, 2019 12:15 PM America/New_York

Location Icon JW Marriott Essex House New York, 160 Central Park South, New York, NY

Event info

Register HERE!

The management of patients with aortic valve disease is constantly evolving, highlighted by innovations in devices, surgical techniques, and imaging. In addition, guidelines, research studies and clinical trials are continually expanding the evidence base related to both management decisions and treatment outcomes from valve interventions, both transcatheter and surgical-implanted devices. These developments, in turn, have altered the clinical practice framework for approaching aortic valve disease quantification and treatments, resulting in some confusion regarding the optimal management strategies. This program is designed to bring together cardiologists, surgeons, and other healthcare providers to address the contemporary and future management of aortic valve disease and better define the role of transcatheter and surgical therapies. The course will emphasize case-based learning designed to engage learners in discussions, debates, and critical decision-making for this condition.

Learning Objectives
After participating in this educational activity, practitioners will be able to do the following:

  • Describe the best practices for the assessment and treatment of patients with aortic valve disease.
  • Discuss the role of medical therapy for patients with aortic valve disease.
  • Describe strategies for treating uncommon developments associated with aortic valve disease including use of mechanical or bioprosthesis valves, valve reimplantation, and repair of bicuspid valves.
  • Summarize outcomes for transcatheter aortic valve replacements (TAVR) versus surgical aortic valve replacement in clinical trials of patients at low and intermediate risk for surgical complications.
  • Explain how recently presented results from clinical trials in lower surgical-risk patients, especially longer-term outcomes, are expanding the patient-eligibility criteria for TAVR.

Target Audience:

This course is intended for cardiothoracic surgeons, cardiologists, interventional cardiologists, internists, nurses, physician assistants and all health care professionals involved in the evaluation, diagnosis and/or management of patients with aortic valve disease.

Cleveland Clinic has ranked as the nation’s #1 heart care program for 24 consecutive years by U.S. News & World Report.

Upcoming live Cleveland Clinic CME activities for cardiovascular specialists:

Course Syllabus

Click HERE to view the syllabus

5 others would like to attend.

I need an invite

Login to view comments. Click here to Login